The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
A supportive care intervention for people with metastatic melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability
Abstract
Introduction: Increasing numbers of metastatic melanoma (MM) patients are receiving immunotherapy treatment, including pembrolizumab, and the impact on their well-being is underexplored. Objectives: To assess the feasibility of a multimodal supportive care program to MM patients being treated with pembrolizumab. Methods: This pre-post-test feasibility cohort study recruited MM participants treated with pembrolizumab: (i) supportive care intervention with usual care and (ii) usual care. The intervention comprised comprehensive medical assessment by supportive care physician (SCP), exercise physiologist (EP), and dietitian then a tailored supportive care program. Programs included exercise, dietary advice, non-invasive complementary therapies, and psychology consultation. Outcome measures included adherence, patient-reported symptoms, anxiety and depression, and toxicity. Descriptive data are reported. Results: We recruited 28 participants: 13 intervention and 15 control; three did not complete the study. Most were male, with median age 66 (range 42–85) years. All intervention participants completed baseline assessments with SCP, EP, and dietitian. Two missed follow-up with EP or dietitian. Symptoms most troubling at baseline were as follows: fatigue (n = 6), sleep (n = 6), general aches and pains (n = 5), and memory (n = 4). All intervention participants were prescribed 16 exercise sessions; 8 (50%) completed all; overall exercise adherence was 85%. Integrative therapies were accessed by 85% (11) participants. Immunotherapy-related adverse event rates were low and SCP consultation identified symptoms not captured by CTCAE 4.0. Conclusions: A holistic supportive care intervention tailored to individual needs is feasible. The symptom burden in MM patients was low. Further investigation of the intervention is warranted, focused on populations with higher symptom burden to improve outcomes. © 2018, Springer-Verlag GmbH Germany, part of Springer Nature.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000678 · Cited by 7,482
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J. J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503093 · Cited by 5,887
Self-citationOverall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Wolchok, J. D., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J.-J., Cowey, C. L., Lao, C. D., Wagstaff, J., Schadendorf, D., Ferrucci, P. F., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709684 · Cited by 5,357
Schachter, J., Ribas, A., Long, G. V., Arance, A., Grob, J.-J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31601-x · Cited by 1,225
Self-citationExercise for the management of cancer-related fatigue in adults
Cramp, F., & Byron-Daniel, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006145.pub3 · Cited by 1,096
Cancer-Related Fatigue, Version 2.2015
Berger, A. M., Mooney, K., Alvarez-Perez, A., Breitbart, W. S., Carpenter, K. M., Cella, D., Cleeland, C., Dotan, E., Eisenberger, M. A., Escalante, C. P., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0122 · Cited by 949
Kotronoulas, G., Kearney, N., Maguire, R., Harrow, A., Di Domenico, D., Croy, S., & MacGillivray, S. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5948 · Cited by 946
Research works printed but not linked: 1
- Office QoL (2018) Calculating nom-based T-scores from your FACT-G data. POCOG, University of Sydney, Sydney Available from: www.pocog.org.au/pod/factgscores.aspx
Cited by
Deshpande, R. P., Sharma, S., & Watabe, K. (2020) · Cancers · doi:10.3390/cancers12102983 · Cited by 107
“Low symptom burden Not clear Metastatic melanoma – [95]”
BackgroundLi, H., Wong, C. L., Jin, X., Chen, J., Chong, Y. Y., & Bai, Y. (2021) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2021.103876 · Cited by 81
Levy, D., Dhillon, H. M., Lomax, A. J., Marthick, M., McNeil, C. M., Kao, S. C.-H., & Lacey, J. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4443-3 · Cited by 69
Self-citationKolsteren, E. E. M., Deuning‐Smit, E., Chu, A. K., van der Hoeven, Y. C. W., Prins, J. B., van der Graaf, W. T. A., van Herpen, C. M. L., van Oort, I. M., Lebel, S., Thewes, B., et al. (2022) · Cancers · doi:10.3390/cancers14163889 · Cited by 77
“The EuroQol 5D (EQ-5D; n = 11), the 36- or 12-item Short-Form Health Survey (SF-36; SF-12, n = 6), the Edmonton Symptom Assessment System (ESAS); n = 2), the Assessment of Quality of Life (AQol-8D; n = 1), the Cancer Institute Quality of Life Questionnaire (CI-QOL-Q; n = 1), the Functional Assessment of Chronic Illnes…”
Thomsen, S. N., Lahart, I. M., Thomsen, L. M., Fridh, M. K., Larsen, A. T. S., Mau‐Sørensen, M., Bolam, K. A., Fairman, C. M., Christensen, J. F., & Simonsen, C. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101937 · Cited by 67
Leme, A. C., Haines, J., Tang, L., Dunker, K., Tucunduva Philippi, S., Fisberg, M., Ferrari, G. L., & Fisberg, R. M. (2020) · doi:10.20944/preprints202008.0299.v1 · Cited by 49
“Ten studies [40,41,43,48,51-56,69] showed small improvements on youth weight status as measured by BMI, BMI zscores, or percent prevalence for being overweight/obese.”
BackgroundTorregrosa, C., Chorin, F., Beltran, E. E. M., Neuzillet, C., & Cardot‐Ruffino, V. (2022) · Cancers · doi:10.3390/cancers14215402 · Cited by 54
Zwanenburg, L. C., Suijkerbuijk, K. P. M., van Dongen, S. I., Koldenhof, J. J., van Roozendaal, A. S., van der Lee, M. L., & Schellekens, M. P. J. (2022) · Journal of Cancer Survivorship · doi:10.1007/s11764-022-01306-9 · Cited by 45
“Such supportive care could prevent the development of psychopathology [15].”
BackgroundTakemura, K. N., Yonekura, S., Downey, L. E., Evangelopoulos, D., & Heng, D. Y. C. (2022) · European Urology Open Science · doi:10.1016/j.euros.2022.03.002 · Cited by 32
Can Exercise Enhance the Efficacy of Checkpoint Inhibition by Modulating Anti-Tumor Immunity?
Brummer, C., Pukrop, T., Wiskemann, J., Bruß, C., Ugele, I., & Renner, K. (2023) · Cancers · doi:10.3390/cancers15184668 · Cited by 26
Patient-Reported Outcomes in Integrative Oncology: Bridging Clinical Care With Research
Lopez, G., Lacey, J., Christie, A. J., Powers-James, C. R., Narayanan, S., Liu, W., & Cohen, L. G. (2019) · The Cancer Journal · doi:10.1097/ppo.0000000000000401 · Cited by 27
Self-citationPizzutilo, E. G., Romanò, R., Roazzi, L., Agostara, A. G., Oresti, S., Zeppellini, A., Giannetta, L. G., Cerea, G., Signorelli, D., Siena, S., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0161 · Cited by 20
Shaver, A. L., Sharma, S., Nikita, N., Lefler, D. S., Basu-Mallick, A., Johnson, J. M., Butryn, M. L., & Lu-Yao, G. L. (2021) · Cancers · doi:10.3390/cancers13246364 · Cited by 25
Crosby, B. J., Newton, R. U., Galvao, D. A., Taaffe, D. R., López, P., Meniawy, T. M., Khattak, M. A., Lam, W., Gray, E. S., & Singh, F. (2023) · Cancer Medicine · doi:10.1002/cam4.6091 · Cited by 20
Hyatt, A., Gough, K., Murnane, A., Au‐Yeung, G., Dawson, T., Pearson, E. J. M., Dhillon, H. M., Sandhu, S. K., Williams, N., Paton, E., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-036059 · Cited by 19
Self-citationCrosstalk between Exercise and Immunotherapy: Current Understanding and Future Directions
Liu, J., Liu, W. L., Wan, Y., & Mao, W. (2024) · Research · doi:10.34133/research.0360 · Cited by 18
Handford, J., Chen, M., Rai, R., Moss, C. L., Enting, D., Peat, N., Karagiannis, S. N., Hemelrijck, M. V., & Russell, B. A. (2022) · Cancers · doi:10.3390/cancers14205039 · Cited by 15
“Most studies addressing QoL used outcome measures relating to symptom burden, with only Lacey et al. [39] incorporating a global measure of HRQoL.”
BackgroundMethodInfluentialIntegrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours
Fuller-Shavel, N., & Krell, J. (2024) · Current Oncology Reports · doi:10.1007/s11912-023-01492-4 · Cited by 14
“Two small prospective exercise programme pilots of 28–30 participants have also been completed, focusing on demonstrating feasibility with quality-of-life evaluation [58, 59].”
BackgroundThompson, J., Salam, R. A., Hanna, S. M., Dieng, M., Saw, R. P. M., & Bartula, I. (2023) · Cancer Medicine · doi:10.1002/cam4.6012 · Cited by 8
Shallwani, S. M., Ranger, M.-C., Thomas, R. L., Brosseau, L., Poitras, S., Sikora, L., & KING, J. A. C. (2020) · Palliative & Supportive Care · doi:10.1017/s1478951520001327 · Cited by 12
“28 patients with metastatic melanoma treated with immunotherapy (Lacey et al., 2019) Tailored supportive care intervention ×8 wks including exercise, dietary advice, noninvasive complementary therapies (massage, reflexology yoga, qigong, mindfulness meditation, or acupuncture), and psychology consultation Pre-post-tes…”
BackgroundCeci, C., García‐Chico, C., Atzori, M. G., Lacal, P. M., Lista, S., Santos‐Lozano, A., Graziani, G., & Pinto-Fraga, J. (2023) · Journal of Cancer · doi:10.7150/jca.88559 · Cited by 9
Naehrig, D. N., Dhillon, H. M., Asher, R., Grimison, P., Grant, S. J., & Lacey, J. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06028-9 · Cited by 8
Self-citationCrosby, B. J., López, P., Galvao, D. A., Newton, R. U., Taaffe, D. R., Meniawy, T. M., Warburton, L., Khattak, M. A., Gray, E. S., & Singh, F. (2021) · Integrative Cancer Therapies · doi:10.1177/15347354211040757 · Cited by 8
Kumar, B., Htaa, M. T., Kerin‐Ayres, K., Smith, A. L., Lacey, J., Browne, S. B., & Grant, S. (2024) · Journal of Cancer Survivorship · doi:10.1007/s11764-024-01714-z · Cited by 11
“Finally, the combining multimodal therapy with immunotherapy reduced symptom burden [96].”
Self-citationSaw, R. P. M., Bartula, I., Winstanley, J. B., Morton, R. L., Dieng, M., Lai-Kwon, J. E., Thompson, J., & Mostafa, N. (2022) · Springer eBooks · doi:10.1007/978-3-030-84702-9_26 · Cited by 7
A systematic review of patient-reported outcome measures for advanced skin cancer patients
Reinhardt, M. E., Sun, T., Pan, C. X., Schmults, C. D., Lee, E. H., & Waldman, A. (2022) · Archives of Dermatological Research · doi:10.1007/s00403-022-02479-0 · Cited by 5
Buro, A. W., Crowder, S. L., Rozen, E., Stern, M., & Carson, T. L. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043355 · Cited by 7
“Study Diet PA Psychological or QOL Adamsen, 2006 [36] N/A 1RM and VO2 max; improved muscular strength (p < 0.001), physical fitness (p < 0.001) and PA levels (p < 0.001) EORTC QLQ-C30, SF-36; improved physical functioning (p < 0.001) and role functioning (p < 0.001) Midtgaard, 2006 [37] N/A Interview and quantitative…”
BackgroundInfluentialMendoza, T. R., Hong, D. S., Peterson, C. B., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16588-3 · Cited by 4
Boileau, M., Templier, C., Massip, E., Dehoux, C., Dziwniel, V., Fabre, C., Thévenon, A., & Mortier, L. (2023) · Melanoma Research · doi:10.1097/cmr.0000000000000889 · Cited by 4
Lynch, F., Rodin, G., Jefford, M., Duffy, M., Lai-Kwon, J. E., Heynemann, S., Mileshkin, L., Briggs, L., Burke, J. M., Leigh, L., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-072322 · Cited by 6
Zwanenburg, L. C., van Roekel, E., Suijkerbuijk, K. P. M., Koldenhof, J. J., Schuurbiers-Siebers, O. C. J., van der Stap, J., van der Lee, M. L., & Schellekens, M. P. J. (2025) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaf042 · Cited by 6
Jackson-Carroll, N., Whisenant, M., Crane, S. M., & Johnson, C. (2023) · Cancer Nursing · doi:10.1097/ncc.0000000000001299 · Cited by 5
RETRACTED: Physical activity and glioblastoma: a paradigm shift in neuro-oncology therapy
Xie, L., & Wang, F. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1638060 · Cited by 5
RetractedExercise interventions for older adults with advanced cancer: A scoping review
Sattar, S., Haase, K. R., Tejero, I., Bradley, C., Cobbing, S., Pathak, N., Callow, J. H., Lam, J. A., Perlon, C., Socorro, K. J. D., et al. (2025) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2025.102237 · Cited by 3
Thompson, J., McCutcheon, T. B., Martin, L. K., Saw, R. P. M., Bartula, I., & Boyle, F. M. (2025) · JAMA Dermatology · doi:10.1001/jamadermatol.2025.2287 · Cited by 4
Zubac, D., Niels, T., & Baumann, F. T. (2025) · European Journal of Applied Physiology · doi:10.1007/s00421-025-05845-8 · Cited by 4
“Exercise is known to be feasible and safe in ICI patients (Lacey et al. 2019; Schneider et al. 2020a, b), but still data on cardiometabolic profile of patients under ICI treatment are unknown.”
The Role of Prehabilitation in Oncology Patients Undergoing Complex Systemic Anticancer Therapy
Renouf, T. (2025) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2025.151812 · Cited by 2
Zhang, H., Wang, S., Zhao, Q., Han, R., Tao, J., & Yin, Y. (2025) · Psycho-Oncology · doi:10.1002/pon.70211 · Cited by 2
Boileau, M., Gehenne, L., Dehoux, C., Dziwniel, V., Fabre, C., Templier, C., & Mortier, L. (2024) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2024.103317 · Cited by 1
Campbell, K. L., & Kirkham, A. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-42011-6_8 · Cited by 1
Szuba, J., Rędaszka, M., Barańska, O., Chańko, M., Drożdżał, J., Krzaczkowski, A., Niedzieska, E., Szular, Z., Wojczulis, T., & Ziemek, K. (2025) · Quality in Sport · doi:10.12775/qs.2025.43.62381
Pichel, R. C., Soares‐Miranda, L., Miranda, H. M., Vale, S. M. C. G., Coelho, J. Q., Guerra, L. P., Braga, M. M., Pinhol, G., Fidalgo, P., Araújo, A., et al. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09824-9 · Cited by 2
“Interestingly, patients without problems in self-care or in usual activities spend more time doing MVPA, and patients without problems in mobility, self-care, or pain/discomfort reported less fatigue and a higher index of global health.”
Metadata
- Authors
- Lacey, J., Lomax, A. J., McNeil, C., Marthick, M., Levy, D., Kao, S., Nielsen, T., & Dhillon, H. M.
- Affiliations
- The University of Sydney (AU)
- Chris O’Brien Lifehouse (AU)
- Corresponding author
- Lacey, Judith
- Venue
- Supportive Care in Cancer
- Published
- 2018-11-03
- Volume
- 27
- Issue
- 4
- Pages
- 1497-1507
- ISSN
- 0941-4355 (ISSN-L)
- 1433-7339
- OpenAlex
- W2898934815
- Cited by
- 42
- References
- 38
- Citations by year
- 2025: 9 · 2024: 4 · 2023: 10 · 2022: 8 · 2021: 4 · 2020: 5 · 2019: 1 · 2018: 1
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Supportive Care in Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- MSD Ltd (N/A)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Keywords
- metastatic melanoma, pembrolizumab, immunotherapy, supportive care, exercise intervention, dietary recommendations, integrative therapy, symptom burden, fatigue, anxiety and depression, immunotherapy toxicity, feasibility, patient-reported outcomes, holistic care
- MeSH terms
- Adult, Aged, Aged, 80 and over, Combined Modality Therapy, Diet Therapy, Exercise Therapy, Feasibility Studies, Female, Humans, Immunotherapy, Male, Melanoma, Middle Aged, Neoplasm Metastasis, Palliative Care, Patient Acceptance of Health Care, Perception, Pilot Projects, Quality of Life, Cohort Studies, Risk Assessment, Musculoskeletal Manipulations, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.